Expanded bed protein A affinity chromatography of a recombinant humanized monoclonal antibody: process development, operation, and comparison with a packed bed method

被引:36
作者
Fahrner, RL [1 ]
Blank, GS [1 ]
Zapata, GA [1 ]
机构
[1] Genentech Inc, Dept Recovery Sci, S San Francisco, CA 94080 USA
关键词
recombinant antibody; preparative chromatography; expanded bed;
D O I
10.1016/S0168-1656(99)00169-8
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We show that expanded bed protein A affinity chromatography using Streamline rProtein A. media is an efficient method for purifying a recombinant humanized monoclonal antibody from unclarified Chinese hamster ovary cell culture fluid and that it provides purification performance comparable to using a packed bed. We determined that the dynamic capacity of the expanded bed media is related to flow rate (measured in column volumes per hour) by a power function, which allows a high capacity at a low flow rate. At 250 cm h(-1) with a 25 cm bed height (10 column volumes h(-1)), the dynamic capacity is 30 g l(-1). The yield and purity (measured by the amount of host cell proteins, DNA, SDS-PAGE, and turbidity) of the antibody purified by expanded bed is comparable to the yield and purity obtained on a standard packed bed method using Prosep A media. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 30 条
[1]   Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma [J].
Anderson, DR ;
GrilloLopez, A ;
Varns, C ;
Chambers, KS ;
Hanna, N .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) :705-708
[2]   Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].
Baselga, J ;
Tripathy, D ;
Mendelsohn, J ;
Baughman, S ;
Benz, CC ;
Dantis, L ;
Sklarin, NT ;
Seidman, AD ;
Hudis, CA ;
Moore, J ;
Rosen, PP ;
Twaddell, T ;
Henderson, IC ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744
[3]  
Batt Brian C., 1995, Bioseparation, V5, P41
[4]  
Bodey B, 1996, ANTICANCER RES, V16, P517
[5]   HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY [J].
CARTER, P ;
PRESTA, L ;
GORMAN, CM ;
RIDGWAY, JBB ;
HENNER, D ;
WONG, WLT ;
ROWLAND, AM ;
KOTTS, C ;
CARVER, ME ;
SHEPARD, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4285-4289
[6]   DEVELOPMENT OF AN EXPANDED BED TECHNIQUE FOR AN AFFINITY PURIFICATION OF G6PDH FROM UNCLARIFIED YEAST-CELL HOMOGENATES [J].
CHANG, YK ;
MCCREATH, GE ;
CHASE, HA .
BIOTECHNOLOGY AND BIOENGINEERING, 1995, 48 (04) :355-366
[7]  
Chang YK, 1996, BIOTECHNOL BIOENG, V49, P204
[8]   Zn2+-selective purification of recombinant proteins from the milk of transgenic animals [J].
Degener, A ;
Belew, M ;
Velander, WH .
JOURNAL OF CHROMATOGRAPHY A, 1998, 799 (1-2) :125-137
[9]   ISOLATION OF PURE IGG1, IGG2A AND IGG2B IMMUNOGLOBULINS FROM MOUSE SERUM USING PROTEIN A-SEPHAROSE [J].
EY, PL ;
PROWSE, SJ ;
JENKIN, CR .
IMMUNOCHEMISTRY, 1978, 15 (07) :429-436
[10]  
Frej AKB, 1996, BIOSEPARATION, V6, P265